Tyrosine kinase inhibitors in cancer therapySrinivasan Madhusudan, Trivadi S. Ganesan|Clinical Biochemistry|2004Cited by 239
A Phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor α Inhibitor in Patients with Metastatic Breast CancerSrinivasan Madhusudan, Adrian L. Harris, Martin D. Foster et al.|Clinical Cancer Research|2004Cited by 204
Study of Etanercept, a Tumor Necrosis Factor-Alpha Inhibitor, in Recurrent Ovarian CancerSrinivasan Madhusudan, Trivadi S. Ganesan, S. Muthuramalingam et al.|Journal of Clinical Oncology|2005Cited by 166
A Multicenter Phase I Gene Therapy Clinical Trial Involving Intraperitoneal Administration of E1A-Lipid Complex in Patients with Recurrent Epithelial Ovarian Cancer Overexpressing HER-2/<b> <i>neu</i> </b> OncogeneSrinivasan Madhusudan, Trivadi S. Ganesan, Nicholas R. Lemoine et al.|Clinical Cancer Research|2004Cited by 69
Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinomaG. Deplanque, Adrian L. Harris, Srinivasan Madhusudan et al.|British Journal of Cancer|2004Cited by 20